Herpes simplex virus glycoproteins: participation of individual herpes simplex virus type 1 glycoprotein antigens in immunocytolysis and their correlation with previously identified glycopolypeptides.
about
In vivo modulation of vaccine-induced immune responses toward a Th1 phenotype increases potency and vaccine effectiveness in a herpes simplex virus type 2 mouse model.Participation of three major glycoprotein antigens of herpes simplex virus type 1 early in the infectious cycle as determined by antibody-dependent cell-mediated cytotoxicity.Herpes simplex virus glycoproteins: isolation of mutants resistant to immune cytolysisComparative structural analysis of glycoprotein gD of herpes simplex virus types 1 and 2.Mutant analysis of herpes simplex virus-induced cell surface antigens: resistance to complement-mediated immune cytolysisAnalysis of the role of antibody-dependent cellular cytotoxic antibody activity in murine neonatal herpes simplex virus infection with antibodies to synthetic peptides of glycoprotein D and monoclonal antibodies to glycoprotein BUnusual lectin-binding properties of a herpes simplex virus type 1-specific glycoproteinHerpes simplex virus-2 (HSV-2) type-specific antibody correlates of protection in infants exposed to HSV-2 at birth.Prediction and identification of potential immunodominant epitopes in glycoproteins B, C, E, G, and I of herpes simplex virus type 2Intratypic and intertypic specificity of lymphocytes involved in the recognition of herpes simplex virus glycoproteins.Protection against lethal challenge of BALB/c mice by passive transfer of monoclonal antibodies to five glycoproteins of herpes simplex virus type 2.Use of monoclonal antibodies for analysis of antibody-dependent immunity to ocular herpes simplex virus type 1 infection.Use of monoclonal antibody directed against herpes simplex virus glycoproteins to protect mice against acute virus-induced neurological diseaseImmunological reactivity of herpes simplex virus 1 and 2 polypeptides electrophoretically separated and transferred to diazobenzyloxymethyl paper.Assay of type-specific and type-common antibodies to herpes simplex virus types 1 and 2 in human seraSynthesis and processing of glycoproteins gD and gC of herpes simplex virus type 1.gA and gB glycoproteins of herpes simplex virus type 1: two forms of a single polypeptide.Protection from herpes simplex virus type 1 lethal and latent infections by secreted recombinant glycoprotein B constitutively expressed in human cells with a BK virus episomal vector.Humoral immune response to herpes simplex virus type 2 glycoproteins in patients receiving a glycoprotein subunit vaccine.Characterization and mapping of a nonessential pseudorabies virus glycoprotein.Molecular basis of the glycoprotein C-negative phenotypes of herpes simplex virus type 1 mutants selected with a virus-neutralizing monoclonal antibodyEpstein-Barr virus glycoprotein homologous to herpes simplex virus gB.Isolation, characterization, and physical mapping of a pseudorabies virus mutant containing antigenically altered gp50.Herpes simplex virus type 1 glycoprotein C-negative mutants exhibit multiple phenotypes, including secretion of truncated glycoproteinsBiochemical characterization of peptides from herpes simplex virus glycoprotein gC: loss of CNBr fragments from the carboxy terminus of truncated, secreted gC moleculesHuman leukocytes kill varicella-zoster virus-infected fibroblasts in the presence of murine monoclonal antibodies to virus-specific glycoproteinsEpitopes of herpes simplex virus type 1 glycoprotein gC are clustered in two distinct antigenic sitesPhysical mapping of the mutation in an antigenic variant of herpes simplex virus type 1 by use of an immunoreactive plaque assayHerpes simplex virus type 2 glycoprotein gF and type 1 glycoprotein gC have related antigenic determinantsGenetic and phenotypic analysis of herpes simplex virus type 1 mutants conditionally resistant to immune cytolysisLocalization and synthesis of an antigenic determinant of herpes simplex virus glycoprotein D that stimulates the production of neutralizing antibody.Cells expressing herpes simplex virus glycoprotein gC but not gB, gD, or gE are recognized by murine virus-specific cytotoxic T lymphocytes.Immunogenicity of herpes simplex virus glycoproteins gC and gB and their role in protective immunity.Antigenic variants of herpes simplex virus selected with glycoprotein-specific monoclonal antibodies.Glycoprotein D protects mice against lethal challenge with herpes simplex virus types 1 and 2.Human T-lymphocyte response in vitro to synthetic peptides of herpes simplex virus glycoprotein D.Lysis of herpes simplex virus-infected cells early in the infectious cycle by human antiviral antibody and complementSynthesis and processing of bovine herpesvirus 1 glycoproteins.Modification of viral structural proteins of herpesvirus sylvilagus by glycosylation and phosphorylation.Kinetics of expression of herpes simplex virus type 1-specific glycoprotein species on the surfaces of infected murine, simian, and human cells: flow cytometric analysis.
P2860
Q33639596-2431A4FB-A8A0-4D8C-BE19-55AB376BC280Q33901808-AFDB8E76-06EF-4266-A038-B42E05F70D4AQ33918943-20205B55-6C0B-41CF-B261-F0C14082060FQ33923748-8B710B0D-CF85-47FB-B731-4A134B567220Q33925072-3F97003A-9D16-477B-ABBD-F6D5242BFF17Q34256508-15C5B076-E51D-4C60-B749-2F2F53E407A6Q35237739-7EA008D0-46AD-42EE-93C5-D78AD22F593DQ35605299-71247DF8-0FED-4983-8D28-C033A39946B2Q35977563-777CA406-502E-4A26-8779-95CF4B298163Q36328865-B7B39C83-1F61-456E-B851-737D1C68849DQ36333640-5A97631F-D762-4F69-A91E-17FC0EB2708BQ36335255-ED64C8E7-61B2-4DC5-A011-B1D35EC8B7D1Q36429254-DE85E0DD-79CC-4C32-8163-E2A34A173E23Q36442697-0C723F2D-F0F9-4EF9-B31C-788AA2CE3DC8Q36444916-35762D1B-B195-4B90-9D06-37C202C391CAQ36507398-0E5082BC-AC91-4FE7-ACD3-EEBFF4ADA64EQ36508282-368E1EC0-6233-46D9-9FDE-5F1546B09756Q36799854-CD7FAAF2-8B3B-4D50-B68E-10E6C3B2C93DQ36852943-90A94F1D-5D72-4E11-B03A-637E4CC8AB93Q36861204-E30D34E5-0D2D-4A3E-A95D-AC6E80D01E47Q36861859-8AC6F384-A2A3-4B7B-A603-FE8D6B114598Q36884762-99338457-9BD8-4430-BC02-A7CB84153908Q36892425-7E7D9B81-0A35-4E8D-A32B-5D54D7800D35Q36895826-A42B210F-35EF-4E93-BAC1-7482BD9E5D0BQ36896485-B25A8DC9-305E-4EC2-A3A5-EE8C937EDD25Q36900327-6C04BB1E-1E3A-44D1-A899-7B7C6A492C60Q36903869-49476E44-671C-41FA-BC9B-B1DFB17D4B1AQ36906452-B0BEDD05-4C76-4465-BD2B-ABECFD89BB42Q36906946-A1581063-CF27-4800-9689-CBF2461795D8Q36908014-03BFC661-C213-4370-A9E6-7234D23AE9E9Q36910738-2AD639EA-A3E0-48C7-AA84-0C21A0E21517Q36916007-8FEDE247-1AD0-4E40-BBA4-CD61EC009F5FQ36917531-08C3023B-0442-4403-9172-ACDDB72F436CQ36930264-04CF6712-B7FD-4FC0-811E-DF80F0D565DBQ37099580-9DB2B9C2-4D0F-41D0-8731-BBB743986308Q37688772-7A9EEA20-A290-49AE-B3B2-5E5B3C8A19A4Q38584064-5E24DCDB-9C67-4FE1-893B-C89DA8D5C8FCQ40127224-587FE836-5A4B-4680-8B3F-DB3B9CE5AE12Q40134691-CE74E720-5398-459D-B881-AF79949348BFQ40137521-3B14EF32-D5E9-4274-9AF9-9D00B6D8EE68
P2860
Herpes simplex virus glycoproteins: participation of individual herpes simplex virus type 1 glycoprotein antigens in immunocytolysis and their correlation with previously identified glycopolypeptides.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 1979
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Herpes simplex virus glycoprot ...... identified glycopolypeptides.
@en
Herpes simplex virus glycoprot ...... identified glycopolypeptides.
@nl
type
label
Herpes simplex virus glycoprot ...... identified glycopolypeptides.
@en
Herpes simplex virus glycoprot ...... identified glycopolypeptides.
@nl
prefLabel
Herpes simplex virus glycoprot ...... identified glycopolypeptides.
@en
Herpes simplex virus glycoprot ...... identified glycopolypeptides.
@nl
P2093
P2860
P1433
P1476
Herpes simplex virus glycoprot ...... identified glycopolypeptides.
@en
P2093
P2860
P304
P407
P577
1979-12-01T00:00:00Z